ASCO 2025 Plenary: SERENA-6
Two Onc Docs
00:00
Exploring the Serena 6 Trial: Advancements in Breast Cancer Treatment
This chapter discusses the Serena 6 trial, exploring the efficacy of camisetrant combined with CDK4-6 inhibitors in treating advanced hormone receptor-positive breast cancer. It highlights trial design, key findings such as progression-free survival improvements, and the implications of using circulating tumor DNA in patient management.
Transcript
Play full episode
